175 related articles for article (PubMed ID: 37843550)
1. Ginsenoside Rh4 inhibits inflammation-related hepatocellular carcinoma progression by targeting HDAC4/IL-6/STAT3 signaling.
Jiang R; Luo S; Zhang M; Wang W; Zhuo S; Wu Y; Qiu Q; Yuan Y; Jiang X
Mol Genet Genomics; 2023 Nov; 298(6):1479-1492. PubMed ID: 37843550
[TBL] [Abstract][Full Text] [Related]
2. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
Ding H; Zhang X; Su Y; Jia C; Dai C
Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532
[TBL] [Abstract][Full Text] [Related]
3. Total flavonoids of Radix Tetrastigma suppress inflammation-related hepatocellular carcinoma cell metastasis.
Liu Z; Ding F; Shen X
Mol Genet Genomics; 2021 May; 296(3):571-579. PubMed ID: 33576897
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
Ding H; Liu J; Zou R; Cheng P; Su Y
J Exp Clin Cancer Res; 2019 May; 38(1):189. PubMed ID: 31072375
[TBL] [Abstract][Full Text] [Related]
5. circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma.
Chen W; Li Y; Zhong J; Wen G
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880589
[TBL] [Abstract][Full Text] [Related]
6. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
Huang B; Huang M; Li Q
Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
[TBL] [Abstract][Full Text] [Related]
7. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
[TBL] [Abstract][Full Text] [Related]
8. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
Ding Z; Guo L; Deng Z; Li P
Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
[TBL] [Abstract][Full Text] [Related]
9. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
[TBL] [Abstract][Full Text] [Related]
10. The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.
Yuan JH; Yang F; Chen BF; Lu Z; Huo XS; Zhou WP; Wang F; Sun SH
Hepatology; 2011 Dec; 54(6):2025-35. PubMed ID: 21837748
[TBL] [Abstract][Full Text] [Related]
11. Circ_0004913 Inhibits Cell Growth, Metastasis, and Glycolysis by Absorbing miR-184 to Regulate
Wu M; Sun T; Xing L
Cancer Biother Radiopharm; 2023 Dec; 38(10):708-719. PubMed ID: 33021399
[No Abstract] [Full Text] [Related]
12. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma.
Yin Z; Ma T; Lin Y; Lu X; Zhang C; Chen S; Jian Z
J Cell Biochem; 2018 Nov; 119(11):9419-9432. PubMed ID: 30015355
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
[TBL] [Abstract][Full Text] [Related]
14. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway.
Gong QZ; Xiao D; Gong GY; Xu J; Wen XD; Feng F; Qu W
Curr Cancer Drug Targets; 2019; 19(7):583-593. PubMed ID: 30585547
[TBL] [Abstract][Full Text] [Related]
15. IL-17 Activates the IL-6/STAT3 Signal Pathway in the Proliferation of Hepatitis B Virus-Related Hepatocellular Carcinoma.
Hu Z; Luo D; Wang D; Ma L; Zhao Y; Li L
Cell Physiol Biochem; 2017; 43(6):2379-2390. PubMed ID: 29073625
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).
Tang C; Feng W; Bao Y; Du H
Bioengineered; 2021 Dec; 12(1):2119-2131. PubMed ID: 34057016
[TBL] [Abstract][Full Text] [Related]
17. TO901317 inhibits the development of hepatocellular carcinoma by LXRα/Glut1 decreasing glycometabolism.
Xiong T; Li Z; Huang X; Lu K; Xie W; Zhou Z; Tu J
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G598-G607. PubMed ID: 30817182
[TBL] [Abstract][Full Text] [Related]
18. Extract of
Huang X; Chen Y; Zhang X; Li F; Ye H
Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
[No Abstract] [Full Text] [Related]
19. Dual functions of STAT3 in LPS-induced angiogenesis of hepatocellular carcinoma.
Wang Z; Yan M; Li J; Long J; Li Y; Zhang H
Biochim Biophys Acta Mol Cell Res; 2019 Apr; 1866(4):566-574. PubMed ID: 30521872
[TBL] [Abstract][Full Text] [Related]
20. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
